Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday’s Mid-Day Session
Gainers
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.
Spartan Securities Group Initiates Coverage On Society Pass with Buy Rating, Announces Price Target of $8
Spartan Securities Group analyst Barry Sine initiates coverage on Society Pass (NASDAQ:SOPA) with a Buy rating and announces Price Target of $8.